Alpha Cancer Technologies Inc. Announces Acceptance of Abstract for Online Publication at the 2022 American Society of Clinical Oncology Annual Meeting

April 15, 2022
Press Release
Abstracts will be released to the public on ASCO’s Meeting Library at 5:00 p.m. ET on May 26, 2022

nova business plan writer argumentative essay proofreading services soft viagra tablet source link follow essays on human nature lasix efectos adversos viagra pillendienst best website for metformin cialis super active plus uk basketball https://robsonranchviews.com/article/best-english-essays-spm/4/ https://earthwiseradio.org/editing/essay-comparing-two-characters/8/ cheap generic viagra overnight delivery from canada levitra odt vs viagra see url get link source purchase viagra online from canada see cheap nursing shoes here source url https://themilitaryguide.org/14days/cheap-rhetorical-analysis-essay-writing-website-gb/55/ https://brethrenwoods.org/for-writing-critical-lens-essay/ essay introduction builder 10 minute rule for homework click how do cialis chewable tablets work here https://homemods.org/usc/essays-on-socialism/46/ https://journeysmobilevet.com/edimprove/quanto-costa-viagra-da-50/26/ Toronto, Canada, April 14, 2022 —   Alpha Cancer Technologies Inc. (ACT) a biopharmaceutical company focused on developing and commercializing targeted immuno-oncology and immunology therapies based on its proprietary recombinant human Alpha Fetoprotein (AFP) platform, today announced that an abstract the company submitted has been accepted by American Society of Clinical Oncology (ASCO) for the 2022 ASCO Annual Meeting and will be published in an online supplement of the Journal of Clinical Oncology following the meeting. ASCO will be held in Chicago from June 3-8, 2022.

This year, ASCO received and reviewed more than 6,000 abstracts for the 2022 ASCO Annual Meeting. For more information about the Annual Meeting, please visit: https://conferences.asco.org/am/attend. Per ASCO’s Embargo & Release Information, abstracts will be released to the public on ASCO’s Meeting Library at 5:00 p.m. ET on May 26, 2022.